{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T01:41:00Z","timestamp":1781228460581,"version":"3.54.1"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,9]]},"abstract":"<jats:p>Undifferentiated uterine sarcomas (UUS) are a heterogenous group of high-grade mesenchymal tumors. Although these tumors are highly aggressive, a subset of patients may experience long-term survival. These tumors have previously been divided morphologically into uniform and pleomorphic types. A previous study demonstrated that a mitotic index cutoff of 25 mitoses\/10 high-power fields (corresponding to 11.16 mitotic figures\/mm<jats:sup>2<\/jats:sup>) could successfully divide tumors into 2 prognostic groups with significantly different overall survival. The goals of the current study were to (1) validate this mitotic index cutoff in an independent, multicenter cohort and (2) explore the prognostic value of the mitotic index groups in relation to other clinicopathologic variables. Cases were included from 3 independent institutions: The Norwegian Radium Hospital, The Mayo Clinic, and Sk\u00e5ne University Hospital. A total of 40 tumors were included after central review. All cases were negative for the YWHAE-FAM22A\/B and JAZF1-JJAZ1 translocations. Survival data were available on all patients. In this study, one-third of patients with UUS survived beyond 5 years. The crude (unadjusted) Cox Proportional Hazards model revealed a number of parameters that significantly impacted overall survival, including mitotic index group, patient age, stage, and the presence of tumor necrosis. Classification into the uniform and pleomorphic types was not prognostic. Combining these parameters into an adjusted model revealed that only the mitotic index group and stage were prognostic. On the basis of these findings, it is proposed that UUS be subdivided into \u201cmitogenic\u201d and \u201cnot otherwise specified\u201d types.<\/jats:p>","DOI":"10.1097\/pas.0000000000000894","type":"journal-article","created":{"date-parts":[[2017,6,15]],"date-time":"2017-06-15T22:50:52Z","timestamp":1497567052000},"page":"1231-1237","source":"Crossref","is-referenced-by-count":28,"title":["Validation of a Mitotic Index Cutoff as a Prognostic Marker in Undifferentiated Uterine Sarcomas"],"prefix":"10.1097","volume":"41","author":[{"given":"Elin","family":"Hardell","sequence":"first","affiliation":[{"name":"Department of Oncology-Pathology, Karolinska Institutet"},{"name":"Department of Pathology and Cytology, Karolinska University Hospital, Stockholm"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Josefson","sequence":"additional","affiliation":[{"name":"Department of Oncology-Pathology, Karolinska Institutet"},{"name":"Department of Pathology and Cytology, Karolinska University Hospital, Stockholm"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehran","family":"Ghaderi","sequence":"additional","affiliation":[{"name":"Department of Oncology-Pathology, Karolinska Institutet"},{"name":"Department of Pathology and Cytology, Karolinska University Hospital, Stockholm"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tone","family":"Skeie-Jensen","sequence":"additional","affiliation":[{"name":"Gynecologic Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Westbom-Fremer","sequence":"additional","affiliation":[{"name":"Department of Pathology, Sk\u00e5ne University Hospital, Lund"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth H.","family":"Cheek","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Bell","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Selling","sequence":"additional","affiliation":[{"name":"StatSoft Scandinavia AB, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John K.","family":"Schoolmeester","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"M\u00e5sb\u00e4ck","sequence":"additional","affiliation":[{"name":"Department of Pathology, Sk\u00e5ne University Hospital, Lund"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Davidson","sequence":"additional","affiliation":[{"name":"Pathology, Norwegian Radium Hospital, Oslo University Hospital"},{"name":"Institute for Clinical Medicine, the Medical Faculty, University of Oslo, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph W.","family":"Carlson","sequence":"additional","affiliation":[{"name":"Department of Oncology-Pathology, Karolinska Institutet"},{"name":"Department of Pathology and Cytology, Karolinska University Hospital, Stockholm"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-20230922","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/his.12048","article-title":"Recent developments in uterine mesenchymal neoplasms","volume":"62","author":"Chiang","year":"2013","journal-title":"Histopathology"},{"key":"R4-20230922","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1073\/pnas.1115528109","article-title":"14-3-3 Fusion oncogenes in high-grade endometrial stromal sarcoma","volume":"109","author":"Lee","year":"2012","journal-title":"Proc Natl Acad Sci"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/PAS.0b013e31824a7b1a","article-title":"The clinicopathologic features of YWHAE-FAM22 endometrial stromal sarcomas: a histologically high-grade and clinically aggressive tumor","volume":"36","author":"Lee","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/his.12594","article-title":"Endometrial stromal sarcoma\u2014the new genetic paradigm","volume":"67","author":"Lee","year":"2014","journal-title":"Histopathology"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1038\/modpathol.2015.140","article-title":"Practical issues related to uterine pathology: endometrial stromal tumors","volume":"29","author":"Nucci","year":"2016","journal-title":"Mod Pathol"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/PAS.0000000000000256","article-title":"High-grade endometrial stromal sarcomas heterogenous morphologic and genetic features","volume":"38","author":"Sciallis","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R9-20230922","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1097\/PAS.0b013e31816a3b42","article-title":"Endometrial stromal sarcomas and related high-grade sarcomas: immunohistochemical and molecular genetic study of 31 cases","volume":"32","author":"Kurihara","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1097\/PAS.0b013e31825fa931","article-title":"Cyclin D1 as a diagnostic immunomarker for endometrial stromal sarcoma with YWHAE-FAM22 rearrangement","volume":"36","author":"Lee","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/PAS.0000000000000721","article-title":"Novel High-grade Endometrial Stromal Sarcoma: A Morphologic Mimicker of Myxoid Leiomyosarcoma","volume":"41","author":"Hoang","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R12-20230922","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/gcc.22057","article-title":"Fusion of the ZC3H7B and BCOR genes in endometrial stromal sarcomas carrying an X;22-translocation","volume":"52","author":"Panagopoulos","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"key":"R13-20230922","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1002\/ijc.29141","article-title":"A prognosis based classification of undifferentiated uterine sarcomas: Identification of mitotic index, hormone receptors and YWHAE-FAM22 translocation status as predictors of survival","volume":"136","author":"Gremel","year":"2015","journal-title":"Int J Cancer"},{"key":"R14-20230922","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.humpath.2012.08.007","article-title":"YWHAE-FAM22 endometrial stromal sarcoma: diagnosis by reverse transcription-polymerase chain reaction in formalin-fixed, paraffin-embedded tumor","volume":"44","author":"Isphording","year":"2013","journal-title":"Hum Pathol"},{"key":"R15-20230922","doi-asserted-by":"crossref","first-page":"595","DOI":"10.5858\/2008-132-595-SMTOTU","article-title":"Smooth muscle tumors of the uterus: a practical approach","volume":"132","author":"Toledo","year":"2008","journal-title":"Arch Pathol Lab Med"},{"key":"R16-20230922","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00000478-199406000-00001","article-title":"Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases","volume":"18","author":"Bell","year":"1994","journal-title":"Am J Surg Pathol"},{"key":"R17-20230922","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1002\/(SICI)1097-0142(20000315)88:6<1425::AID-CNCR21>3.0.CO;2-3","article-title":"Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma","volume":"88","author":"Pautier","year":"2000","journal-title":"Cancer"},{"key":"R18-20230922","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1158\/1078-0432.CCR-14-3141","article-title":"Clinically relevant molecular subtypes in leiomyosarcoma","volume":"21","author":"Guo","year":"2015","journal-title":"Clin Cancer Res"},{"key":"R19-20230922","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/PAP.0b013e3181cfb7c2","article-title":"Endometrial stromal sarcomas: a review of potential prognostic factors","volume":"17","author":"Chew","year":"2010","journal-title":"Adv Anat Pathol"},{"key":"R20-20230922","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/01.MP.0000093625.20366.9D","article-title":"Prognostic relevance of mitotic activity in patients with node-negative breast cancer","volume":"16","author":"Medri","year":"2003","journal-title":"Mod Pathol"},{"key":"R21-20230922","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1001\/jamadermatol.2014.635","article-title":"Characteristics and associations of high-mitotic-rate melanoma","volume":"150","author":"Shen","year":"2014","journal-title":"JAMA Dermatol"},{"key":"R22-20230922","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/cncr.23199","article-title":"Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST)","volume":"112","author":"DeMatteo","year":"2008","journal-title":"Cancer"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000478-201709000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T20:08:32Z","timestamp":1719259712000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201709000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000000894","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]}}}